SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $286,000 | -25.1% | 30,000 | +20.0% | 0.54% | +69.3% |
| Q2 2014 | $382,000 | +74.4% | 25,000 | +106.6% | 0.32% | +65.1% |
| Q1 2014 | $219,000 | -31.3% | 12,100 | -60.2% | 0.20% | -51.9% |
| Q3 2013 | $319,000 | -19.0% | 30,400 | -39.7% | 0.40% | -18.8% |
| Q2 2013 | $394,000 | – | 50,400 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |